Replies to post #48215 on Ariad Pharmaceuticals Inc fka ARIA

[Whosetosay]

My perspective, and not all agree, is that partnering is dilutive. Over time, $200m might be cheap, upfront it is unlikely. No easy answers.

I wonder where we would be if the therapeutic dose was 30mg all along.